
Standard dosing of DOACs - UpToDate
This is a simplified table that lists the most common dosing in individuals with normal renal function, normal weight, and lack of concomitant interacting medications (eg, P-glycoprotein inhibitors or …
Atrial fibrillation in adults: Use of oral anticoagulants
Nov 18, 2025 · (See "Supraventricular arrhythmias during pregnancy", section on 'Atrial fibrillation and flutter' and "Anticoagulation during pregnancy and postpartum: Agent selection and dosing".)
Direct oral anticoagulants (DOACs) and parenteral direct ... - UpToDate
Oct 17, 2025 · Direct oral anticoagulants (DOACs) and parenteral direct-acting anticoagulants: Dosing and adverse effects Author: Lawrence LK Leung, MD Section Editor: Pier Mannuccio Mannucci, MD …
LMWH doses in patients with high BMI - UpToDate
Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity.
Venous thromboembolism: Anticoagulation after initial management
Oct 8, 2025 · Comprehensive guide on anticoagulation therapy for venous thromboembolism, covering selection, transition, duration, and monitoring of long-term treatment.
Oral anticoagulants common questions PI - UpToDate
Explore common questions about oral anticoagulants, their uses, benefits, and potential risks on this comprehensive UpToDate resource.
Perioperative management of patients receiving anticoagulants
May 5, 2025 · Comprehensive guide on perioperative management of patients on anticoagulants, covering diagnosis, treatment, and medication options for optimal care.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency - UpToDate
Apr 18, 2025 · INTRODUCTION Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an inherited, X-linked, red blood cell (RBC) disorder caused by a pathogenic variant in the G6PD gene. …
Sign in - UpToDate
Sign in to UpToDate for evidence-based clinical decision support and comprehensive medical information.
DOACs PK and drug interactions - UpToDate
Refer to UpToDate for dosing in specific clinical settings, including nonvalvular AF, VTE treatment, and VTE prophylaxis. Data on clearance may help assess the potential for accumulation in patients with …